a drug used to treat too much iron in the blood caused by blood transfusions. it is being studied in the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not make enough healthy blood cells) and other conditions. deferasirox binds to extra iron in the blood. the drug and the iron are passed from the body in urine. it is a type of chelating agent. also called exjade.
出典:Wikipedia
出典:『Wikipedia』 (2011/02/08 16:21 UTC 版)
Deferasirox (marketed as Exjade) is a rationally-designed oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.